← Search & browse all drugs
NERVOUS SYSTEM › PSYCHOLEPTICS › HYPNOTICS AND SEDATIVES › Hypnotics and sedatives in combination, excl. barbiturates
dipiperonylaminoethanol, combinations
N05CX06
Forms & Strengths
- Fixed-dose combination oral tablets containing dipiperonylaminoethanol
Adult Dosing
- Dosage determined by specific fixed-dose combination product and clinical indication
- Typically administered orally 2 to 3 times daily as directed by product labeling
Pediatric Dosing
- Safety and efficacy in pediatric patients not established; generally not recommended
Indications
- Management of specific neuropsychiatric or psychosomatic conditions as formulated in combination products
Mechanism of Action
- Acts via central nervous system modulation, combining the pharmacodynamic profile of dipiperonylaminoethanol with concomitant active ingredients
Contraindications
- Hypersensitivity to dipiperonylaminoethanol or any component of the formulation
- Severe central nervous system depression or coma
- Significant hepatic or renal impairment where specified by combination components
Adverse Reactions
- Drowsiness and sedation
- Dizziness and orthostatic hypotension
- Anticholinergic effects such as dry mouth and blurred vision
- Gastrointestinal upset
Drug Interactions
- Enhanced central nervous system depression when co-administered with alcohol, opioids, or sedatives
- Potential pharmacokinetic interactions mediated by cytochrome P450 enzyme inhibition or induction depending on combination agents
Curated Content: Needs Vetting Before Put to Clinical Use